编辑丨王多鱼排版丨水成文抗 PD-1 联合仑伐替尼（lenvatinib，一种多靶点受体酪氨酸激酶抑制剂）治疗在多种肿瘤中均显示出临床疗效，但潜在的免疫学机制尚不清楚。2025 年 1 月 30 ...

This important study provides solid evidence to support the anti-tumor potential of citalopram, originally an anti-depression drug, in hepatocellular carcinoma (HCC). In addition to their previous ...

近日，Signal Transduction and Targeted Therapy期刊上发表了同样来自复旦大学附属中山医院樊嘉院士及史颖弘、代智等研究者的研究成果：抑制SRSF1一方面能够全面提升CD8 + ...

因此，该研究结果表明， 咪喹莫特或I型干扰素全身用药联 合咪喹莫特局部外用可能扩大黑色素瘤和三阴性乳腺癌等浅表肿瘤患者的治疗选择，并且改善 PD-1等免疫检查点抑制剂治疗效果，对于 治疗局部肿瘤以及 ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

Immune cells in the bone marrow microenvironment of AML patients are key in distinguishing a response to immunotherapy.

Glioblastoma (GBM), an aggressive form of cancer that grows in the brain or spinal cord, occurs at an incidence rate of about 3/100,000 persons in the Unit | Cancer ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

In the past, Dr. Horowitz had been a paid consultant for Purple Biotech.